Einzelansicht Rollinger

[Back]

Univ.-Prof. Mag. Dr. Judith Maria Rollinger

T: +43-1-4277-55255

judith.rollinger@univie.ac.at

Winter term 2025

251032 VO Pharmakognosie (biogene Arzneimittel, med. Aspekte)

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321036 PR Drogenanalyse - B19 - (5 Kurse)

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

580003 SE SE Journal Club: phytochemistry and bioactive natural products

580007 SE SE Academic training and discussion in Pharmacognosy - for doctoral students

Summer term 2025

321036 PR Drogenanalyse - B19 - (5 Kurse)

322005 VO (Bio)pharmazeutika mit Wirkung auf das Herz-Kreislauf System - M4

322006 VO (Bio)pharmazeutika mit Wirkung auf das Nervensystem - M5

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

322563 VU Phytotherapy: from bench to bedside - M14 - (incl. Exkursion)

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

323007 UE Experimental Methods in Drug Discovery und Preclinical Drug Development - MPS6 - (2 Courses)

580001 SE Journal Club: phytochemistry and bioactive natural products

580005 VU Academic training and discussion in Pharmacognosy - for doctoral students

Winter term 2024

251032 VO Pharmakognosie (biogene Arzneimittel, med. Aspekte)

321001 VO Steop Einführung in die pharmazeutischen Wissenschaften - B1

321036 PR Drogenanalyse - B19 - (5 Kurse)

322001 VO (Bio)pharma. mit Wirkung auf metabol. Störungen & eingeschr. Organ- und Systemfunktionen - M1

322002 VO Antiinfektiva, Antineoplastika und (Bio)pharmazeutika mit Wirkung auf das Immunsystem - M2

322028 VU Ausgewählte Kapitel aus der pharmakognostischen Forschung - M13

322061 VU Pharmakobotanische Exkursion nach La Gamba/Costa Rica - M14

323001 VU Introduction to Drug Discovery and Preclinical Drug Development - MPS1

323002 UE Introduction to Experimental Methods in Drug Discovery and Preclinical Drug Development - MPS1

580003 SE SE Journal Club: phytochemistry and bioactive natural products

580007 SE SE Academic training and discussion in Pharmacognosy - for doctoral students

Mair CE, Grienke U, Draschl C, Kramer C, Richter M, von Grafenstein S et al. Linking ethnopharmacology with phenotypic and virtual screening for the identification of antiviral agents from natural sources. Planta Medica: natural products and medicinal plant research. 2014 Nov;80(16):1378-1378.

Grienke U, Mair CE, Saxena P, Kratz JM, Baburin I, Schuster D et al. The 'Lotus Leave Diet' - A life-threatening experience? hERG channel blocking aporphine alkaloids from Nelumbo nucifera Gaertn. Planta Medica: natural products and medicinal plant research. 2014 Nov;80(16):1370-1370. SL45. doi: 10.1055/s-0034-1394533

Kratz JM, Schuster D, Edtbauer M, Saxena P, Mair CE, Kirchebner J et al. Experimentally Validated hERG Pharmacophore Models as Cardiotoxicity Prediction Tools. Journal of Chemical Information and Modeling. 2014 Oct;54(10):2887-2901. doi: 10.1021/ci5001955

Grienke U, Zoell M, Peintner U, Rollinger JM. European medicinal polypores - A modern view on traditional uses. Journal of Ethnopharmacology. 2014 Jul 3;154(3):564-583. doi: 10.1016/j.jep.2014.04.030

Pfisterer PH, Schuster D, Rollinger JM, Stuppner H. In Silico-Guided Strategies for the Discovery and Rationalization of Bioactive Natural Products. In Hostettmann K, editor, Handbook of Chemical and Biological Plant Analytical Methods. Vol. 3. Chichester, UK. 2014. p. 949-966 doi: 10.1002/9780470027318.a9942

Grienke U, Braun H, Seidel N, Kirchmair J, Richter M, Krumbholz A et al. Computer-Guided Approach to Access the Anti-influenza Activity of Licorice Constituents. Journal of Natural Products. 2014 Mar;77(3):563-570. doi: 10.1021/np400817j

Vuorinen A, Nashev LG, Odermatt A, Rollinger JM, Schuster D. Pharmacophore model refinement for 11β-hydroxysteroid dehydrogenase inhibitors: Search for modulators of intracellular glucocorticoid concentrations. Molecular Informatics. 2014 Jan;33(1):15-25. doi: 10.1002/minf.201300063

Oettl SK, Hubert J, Nuzillard JM, Renault JH, Rollinger JM, Stuppner H. Dereplication of depsides from the lichen Pseudevernia furfuracea by centrifugal partition chromatography combined to<sup>13</sup>C nuclear magnetic resonance pattern recognition. Analytica Chimica Acta. 2014;846(1):60-67. doi: 10.1016/j.aca.2014.07.009

Seiter MA, Salcher S, Rupp M, Hagenbuchner J, Kiechl-Kohlendorfer U, Mortier J et al. Discovery of Sanggenon G as a natural cell-permeable small-molecular weight inhibitor of X-linked inhibitor of apoptosis protein (XIAP). FEBS Open Bio. 2014;4(1):659-671. doi: 10.1016/j.fob.2014.07.001

Kratz JM, Schuster D, Edtbauer M, Saxena P, Mair CE, Kirchebner J et al. hERG pharmacophore models as cardiac toxicity prediction tools: Identification of channel blockers of natural origin. Vitae: revista de Facultad de Química Farmacéutica, Universidad de Antioquia. 2014;21:S31.

Kuehnl S, Schroecksnadel S, Temml V, Gostner JM, Schennach H, Schuster D et al. Lignans from Carthamus tinctorius suppress tryptophan breakdown via indoleamine 2,3-dioxygenase. Phytomedicine. 2013 Oct 15;20(13):1190-1195. doi: 10.1016/j.phymed.2013.06.006

Brandel C, Amharar Y, Rollinger JM, Griesser UJ, Cartigny Y, Petit S et al. Impact of molecular flexibility on double polymorphism, solid solutions and chiral discrimination during crystallization of diprophylline enantiomers. Molecular Pharmaceutics. 2013 Oct 7;10(10):3850-3861. doi: 10.1021/mp400308u

Atanasov AG, Wang JN, Gu SP, Bu J, Kramer MP, Baumgartner L et al. Honokiol: A non-adipogenic PPARγ agonist from nature. Biochimica et Biophysica Acta - General Subjects. 2013 Oct;1830(10):4813-4819. doi: 10.1016/j.bbagen.2013.06.021

Mair CE, Grienke U, von Grafenstein S, Kirchmair J, Liedl KR, Schmidtke M et al. Bioprospecting diverse plant species for antiviral agents against upper respiratory tract infections. Planta Medica: natural products and medicinal plant research. 2013 Sept;79(13):1261-1262.

Walther E, Xu Z, Leitzinger C, Rollinger JM , Grienke U, Kirchmair J et al. Characterisation of pneumococcal neuraminidase (NA) and the effect of neuraminidase inhibitors (NAIs) on NA activity, bacterial growth, and biofilm formation. International Journal of Medical Microbiology. 2013 Sept;303:40-40.

Grienke U, Richter M, Braun H, Kirchmair J, von Grafenstein S, Liedl KR et al. New insights into the anti-influenza activity of licorice constituents. Planta Medica: natural products and medicinal plant research. 2013 Sept;79(13):1174-1175.

Schuster D, Edtbauer M, Kratz JM, Mair CE, Hering S, Rollinger JM. Pharmacophore-based virtual screening as a prioritization tool to assess mechanism-based cardiotoxic effects of small organic molecules. Toxicology Letters. 2013 Aug 28;221:S84-S84. doi: 10.1016/j.toxlet.2013.05.095

Wolber G, Rollinger JM. Virtual screening and target fishing for natural products using 3D pharmacophores. In Jacoby E, editor, Computational Chemogenomics. Singapore: Pan Stanford. 2013. p. 117-139 doi: 10.1201/b15631

Mak L, Liggi S, Tan L, Kusonmano K, Rollinger JM, Koutsoukas A et al. Anti-cancer drug development: Computational strategies to identify and target proteins involved in cancer metabolism. Current Pharmaceutical Design. 2013;19(4):532-577. doi: 10.2174/138161213804581855

Noha SM, Jazzar B, Kuehnl S, Rollinger JM, Stuppner H, Schaible AM et al. Pharmacophore-based discovery of a novel cytosolic phospholipase A <inf>2</inf>α inhibitor. Bioorganic & Medicinal Chemistry Letters. 2012 Jan 15;22(2):1202-1207. doi: 10.1016/j.bmcl.2011.11.093

The potential of polypore extracts to modulate angiogenesis and inflammation: Insights from in vitro screening on endothelial cell proliferation, migration, and leukocyte recruitment

Achenbach, J. (Contributor), Wasilewicz, A. (Contributor), Roggio, A. (Contributor), Grienke, U. (Contributor), Beniddir, M. A. (Contributor), Rollinger, J. M. (Contributor), Fürst, R. (Contributor) & Kirchweger, B. (Speaker)

3 Sept 2025